• HOME
  • ABOUT VCNDD
    • OUR MISSION
    • LEADERSHIP TEAM
    • AREAS OF FOCUS
    • DISCOVERY TEAMS
    • GRANTS AND FOUNDATIONS
  • NEWS AND PUBLICATIONS
    • NEWS
    • PUBLICATIONS
    • PRESENTATIONS
    • PATENTS
  • SCIENTIFIC COMMUNITY
    • FACILITIES AND EQUIPMENT
    • PATENTS
    • COMPOUNDS
    • MLCPN
    • POSTDOCTORAL TRAINING
  • CONTACT
    • ABOUT VANDERBILT
    • CAREERS
    • GIVING

Discovery Teams

  • MEDICINAL CHEMISTRY
    Craig Lindsley
  • MOLECULAR PHARMACOLOGY
    Colleen Niswender
  • DRUG METABOLISM AND PHARMACOKINETICS
    Scott Daniels
  • BEHAVIORAL PHARMACOLOGY
    Carrie Jones

News

  • Pioneering Partnership with MJFF Drives New Parkinson's Treatment Toward Phamacy Shelves
  • Vanderbilt's Neuroscience Unit Operates Like a Biotech | Elsevier Buisness Intelligence
  • Vanderbilt forges path for academia | Drug Discovery News
  • Studies on Parkinson's drugs blur lines between academia and industry | InsideVandy
  • Bridging the Gap | Chemical & Engineering News
More news >
home | about vcndd | news and publications | scientific commmunity | giving | contact | Vanderbilt University Medical Center

Vanderbilt Center for Neuroscience Drug Discovery | Vanderbilt University Medical Center | 1205 Light Hall | Nashville, TN 37232-0697 | (615) 936-2189 or (615) 936-6427
Vanderbilt University is committed to principles of equal opportunity and affirmative action | Copyright © 2011 by Vanderbilt University Medical Center